# Study Evaluating Pneumococcal Vaccine in Healthy Infants

> **NCT00205803** · PHASE1,PHASE2 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 249 (actual)

## Conditions studied

- Healthy Subjects
- Pneumococcal Infections

## Interventions

- **BIOLOGICAL:** 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)
- **BIOLOGICAL:** 7-Valent Pneumococcal Conjugate Vaccine (7vPnC)

## Key facts

- **NCT ID:** NCT00205803
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 249 (ACTUAL)
- **Last updated:** 2012-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00205803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00205803, "Study Evaluating Pneumococcal Vaccine in Healthy Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00205803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*